The “hub and spoke” model of liver transplant care that is used in some UK regions has been a concept over the past 10 years as described by John O’Grady in 20131.This sounds like a great idea on paper: you can see a patient as the hepatologist with chronic liver disease in clinic in a […]
Latest articles
#FGBlog: New colonoscopy training pathway and certification: will we rise to the challenge?
Colonoscopy is the gold standard technique to assess the lower gastrointestinal tract, allowing direct visualisation of the bowel mucosa, targeted biopsy, and appropriate therapy including resection of precancerous lesions. Although the quality of colonoscopy has improved, there is a still wide variation in quality of colonoscopies performed in the United Kingdom (UK).1, 2 With […]
A Year in Review: the 2022 FG Cup
As 2022 draws to a close we offer our thanks to our authors, reviewers and readers on another productive year! FG is delighted to publish pragmatic and useful advice from experts in the field, enabling practicing gastroenterologists to keep abreast of changing practice. Here we highlight the best of 2022’s papers selected by Editor-in-chief Professor […]
A new approach to coeliac disease diagnosis?
It is well-established that UK endoscopy services are under pressure, with post-Covid waiting lists pushing demand to an all-time high.1 Whilst a no-biopsy approach has been advocated in the diagnosis of coeliac disease (CD) in children since 2012, British Society of Gastroenterology (BSG) guidelines issued in 2014 still advise four duodenal biopsies for the diagnosis […]
#FGBlog – Shape of Training: ready or not
This time of year has always been an uneasy one. At school and university, it signified the end of frivolities and return to the classroom. In our professional career, it has usually signified the time for a change in workplace. Change is something that I, like many others, always struggle to adapt to. I enjoy […]
#FGBlog :Disparity between current guidelines and prescribing in IBD: Is it a lack of awareness or lack of convincing evidence?
It is a well-known fact that the greatest limitation of large randomised controlled trial studies is their lack of external validity with specific patients being excluded from important studies due to their co-morbidities including surgical history (such as ileostomies), age (whether that be children or the elderly) and gender (with females being more likely to […]
A potential new role for faecal calprotectin in monitoring biliary tract disease
Most gastroenterologists have long been familiar with faecal calprotectin (fCal), and it is widely used as a non-invasive test both to screen for the presence of inflammation in those with lower GI symptoms, and to quantitatively monitor disease activity in inflammatory bowel disease (IBD) patients. Calprotectin is a member of the S100 protein family found […]
#FGCup:- Final Score
As January marks the entrance of the ‘big teams’ into the FA Cup, this year we welcomed the ‘big eight’ editor’s choice papers from the past year at Frontline Gastroenterology to compete in the inaugural #FGCup on Twitter. With potential banana skins left right and centre, the form book went out the window as the […]
#FGCup
Despite the ongoing COVID0-19 pandemic, the last year has seen Frontline Gastroenterology continue to publish great content that educates and informs doctors around the world to provide care for their patients. We are grateful to everyone who has submitted their work to us. To celebrate this, we have launched the #FGCup on Twitter to allow […]
Intestinal ultrasound assessment in IBD: another string to the gastroenterologist’s bow?
Although we live in an era of global collaboration, there are a number of circumstances in which gastroenterology practice in the UK is at odds with our European and Australian counterparts. For most UK gastroenterologists, for example, performing and interpreting ultrasound (US) in the outpatient clinic would be out of our comfort zone. Two recent […]